Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Simes

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
The American Journal of Cardiology|March 12, 1999
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapyJ A Puma, M H Sketch, T D Thompson, et al.
Lancet (London, England)|November 12, 2010
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, C Baigent, L Blackwell, et al.
Circulation|February 18, 1997
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) GroupE J Topol, R M Califf, F Van de Werf, et al.
Circulation|November 1, 1993
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality StudyH D White, G I Barbash, M Modan, et al.
Statistics in Medicine|April 29, 1998
Missing quality of life data in cancer clinical trials: serious problems and challengesJ Bernhard, D F Cella, A S Coates, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 5, 2021
Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trialK M Field, E H Barnes, H W Sim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidinesD Ransom, K Wilson, M Fournier, et al.
British Journal of Cancer|November 3, 2005
A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancerS P Ackland, M Jones, D Tu, et al.
Circulation|October 18, 2000
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling ProjectF M Sacks, A M Tonkin, J Shepherd, et al.
Circulation|April 1, 1995
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I InvestigatorsR J Simes, E J Topol, D R Holmes, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|March 12, 1999
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapyJ A Puma, M H Sketch, T D Thompson, et al.
Lancet (London, England)|November 12, 2010
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, C Baigent, L Blackwell, et al.
Circulation|February 18, 1997
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) GroupE J Topol, R M Califf, F Van de Werf, et al.
Circulation|November 1, 1993
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality StudyH D White, G I Barbash, M Modan, et al.
Statistics in Medicine|April 29, 1998
Missing quality of life data in cancer clinical trials: serious problems and challengesJ Bernhard, D F Cella, A S Coates, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 5, 2021
Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trialK M Field, E H Barnes, H W Sim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidinesD Ransom, K Wilson, M Fournier, et al.
British Journal of Cancer|November 3, 2005
A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancerS P Ackland, M Jones, D Tu, et al.
Circulation|October 18, 2000
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling ProjectF M Sacks, A M Tonkin, J Shepherd, et al.
Circulation|April 1, 1995
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I InvestigatorsR J Simes, E J Topol, D R Holmes, et al.
Pageof 15